New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Jaleah Hawkins Authors Study at Rutgers University

(New Brunswick , NJ) February 15, 2010 – Jaleah Hawkins, sales manager for HerbaKraft, Inc., and undergrad at Rutgers University, announced she was the first author for a weight and bone loss study published by the Journal of Nutrition.

The study, initially accepted in November 2009 is entitled: Energy Restriction Is Associated with Lower Bone Mineral Density of the Tibia and Femur in Lean but Not Obese Female Rats.

According to the study in the Journal of Nutrition, reduced bone density is more apparent in lean subjects compared to heavier subjects when diet is restricted. Although the study was done on rats, it warrants attention especially for individuals who are not obese. This category of individuals include models, those fasting to detoxify, and those with eating disorders.

The goal of the study was to observe how bone density and geometry responded to dieting (energy restricted diets). During a 10 week diet (40% food restriction) obese rats lost more weight than the lean rats. Three serum factors were measured in regards to bone synthesis: estradiol, calcefidiol and parathyroid hormone. Estradiol is a major estrogen in humans that affects reproductive organs and bones. Calcefediol, a precursor to active vitamin D undergoes hydroxylation in the liver and is the most sensitive indicator to vitamin D status in the blood. Parathyroid hormone (PTH) is secreted by the parathyroid gland and is responsible for increasing calcium concentration in the blood.

Overall results revealed reduced blood serum levels in lean rats for estradiol, calcefidiol and parathyroid hormone which may have contributed to bone loss. The research suggested that bone metabolism was greatly affected by dietary energy restriction (fasting or dieting) in lean rats. Clinical trials on humans are yet to confirm.

With HerbaKraft, Hawkins is responsible for coordinating sales and marketing activities in the dietary supplement, functional food and cosmeceutical manufacturing industries.

For more information contact Hawkins at 732.463.1000 or by email at [email protected].

# # # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.